Literature DB >> 7582564

R-alpha-methylhistamine-induced inhibition of gastric acid secretion in pylorus-ligated rats via central histamine H3 receptors.

E Barocelli1, V Ballabeni, M Chiavarini, M Impicciatore.   

Abstract

1. The effect of central H3 histamine receptor activation on gastric acid and pepsin production has been investigated in pylorus-ligated rats. 2. Intracerebroventricular injections (i.c.v.) of the selective H3 agonist, R-alpha-methylhistamine (0.5-50 nmol per rat) caused a dose-dependent inhibition of gastric acid secretion while intravenous administration (5-500 nmol per rat) was completely ineffective. 3. I.c.v. microinjections of mepyramine, tiotidine and thioperamide (51 nmol per rat), selective antagonists at H1-, H2- and H3-sites respectively, failed to modify the acid secretory response to pylorus ligation. 4. The antisecretory effect of R-alpha-methylhistamine (5 nmol per rat, i.c.v.) was selectively prevented by the H3-blocker, thioperamide (51 nmol per rat, i.c.v.), mepyramine and tiotidine pretreatment being completely inactive. 5. Unlike acid secretion, pepsin production was not significantly affected by all the tested compounds. 6. These findings provide the first pharmacological evidence that the activation of central H3 histamine receptors exerts a negative control in the regulation of gastric acid secretion in conscious pylorus-ligated rats.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582564      PMCID: PMC1908766          DOI: 10.1111/j.1476-5381.1995.tb15044.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

Review 1.  Plenary lecture. A third histamine receptor subtype: characterisation, localisation and functions of the H3-receptor.

Authors:  J C Schwartz; J M Arrang; M Garbarg; H Pollard
Journal:  Agents Actions       Date:  1990-04

2.  Evidence that histamine H3 receptors are involved in the control of gastric acid secretion in the conscious cat.

Authors:  G Coruzzi; G Bertaccini; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

Review 3.  The histamine H3 receptor: a general presynaptic histaminergic regulatory system?

Authors:  J F van der Werf; H Timmerman
Journal:  Trends Pharmacol Sci       Date:  1989-04       Impact factor: 14.819

4.  Highly potent and selective ligands for histamine H3-receptors.

Authors:  J M Arrang; M Garbarg; J C Lancelot; J M Lecomte; H Pollard; M Robba; W Schunack; J C Schwartz
Journal:  Nature       Date:  1987 May 14-20       Impact factor: 49.962

5.  Involvement of different receptors in the central and peripheral effects of histamine on intestinal motility in the rat.

Authors:  M J Fargeas; J Fioramonti; L Bueno
Journal:  J Pharm Pharmacol       Date:  1989-08       Impact factor: 3.765

6.  Evidence for histaminergic arousal mechanisms in the hypothalamus of cat.

Authors:  J S Lin; K Sakai; M Jouvet
Journal:  Neuropharmacology       Date:  1988-02       Impact factor: 5.250

7.  A modified hemoglobin substrate method for the estimation of pepsin in gastric juice.

Authors:  A Berstad
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

8.  The mechanism of gastric hyperacidity produced by pylorus ligation in the rat.

Authors:  D A Brodie
Journal:  Am J Dig Dis       Date:  1966-03

9.  Localization of central prostaglandin E2 antisecretory effects.

Authors:  E Barocelli; M Impicciatore; J Seaton; R Conter; G Kauffman
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

10.  Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.

Authors:  J M Arrang; M Garbarg; J C Schwartz
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

View more
  1 in total

1.  Gastric antisecretory effects of compound BP 2-94: a histamine H3-receptor agonist prodrug.

Authors:  G Soldani; S Bertini; A Rouleau; J C Schwartz; G Coruzzi
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.